Under Armour: Profitability Beat Masks a Business Still Sliding — Hold

Under Armour reported Q1 fiscal 2027 results today that delivered a profitability beat built on government tariff refunds while the core business weakened further. The company trimmed its full-year revenue outlook from a slight decline to a mid-single-digit drop but maintained its operating-income target. The stock fell 5.3% to $6.40 in today's trading. The question is whether the valuation reset creates a buying opportunity or simply marks another step down a deteriorating path.

The quarterly results: a beat with asterisks

Revenue came in at $1.17 billion, down 3% year-over-year and 4% at constant currency. North America, the company's largest and most important market, declined 9%. International grew 5%, driven by EMEA up 12% and Latin America up 8%, but Asia-Pacific fell 7%. Every product category declined: footwear down 8%, apparel down 2%, and accessories down 4%. The DTC (direct-to-consumer, where Under Armour owns the retail relationship and captures higher margins) channel fell 6%, with e-commerce down 12% and owned stores down 3%. Wholesale declined 2%.

Adjusted diluted EPS was $0.05, beating the consensus estimate of approximately $0.02. Operating income came in at $47 million GAAP, or $52 million on an adjusted basis. The profitability beat was real on a per-share basis, but the earnings quality requires closer inspection.

The gross margin headline misleads

Gross margin came in at 54.1%, up 590 basis points year-over-year. That headline number is misleadingly strong because a substantial portion reflects refunds on IEEPA (International Emergency Economic Powers Act) tariffs that Under Armour expensed in fiscal 2026 after the U.S. Supreme Court ruled those tariff collections illegal.

Management says approximately 150 of the 220 to 270 basis points of gross margin expansion it expects for the full fiscal year comes from these refund recoveries. That means roughly half to two-thirds of the guided margin improvement is a one-time accounting windfall, not a sign of pricing power, product mix improvement, or operating discipline. Strip out the refunds and the margin expansion story shrinks considerably.

The forward guidance tells the starker story

Under Armour lowered its full-year revenue outlook from "a slight decline" to a mid-single-digit decline, with North America and Asia-Pacific both guided to decline. The EPS outlook also weakened, with diluted loss per share expected in a $0.01 to $0.05 range, worse than the prior guidance of breakeven to a $0.04 loss. Adjusted diluted EPS guidance of $0.08 to $0.12 was maintained, but that range sits well below the $0.23 consensus estimate that had been priced in before the Q4 report in May. That gap between guidance and consensus is what drove the stock's 19% plunge in May and remains the overhang on this name.

Operating income guidance of $96 million to $116 million ($140 to $160 million adjusted) was maintained, but includes approximately $70 million in IEEPA refund benefits partially offset by $35 million in Middle East supply chain headwinds. Strip out the refund benefit and the operating target drops by nearly half. The company is effectively using government money to hit its profitability target.

SG&A is expected to decrease at a high-single-digit rate overall, with adjusted SG&A (excluding transformation expenses) declining at a low-single-digit rate. That suggests real cost discipline is happening. The restructuring plan — approximately $305 million in total anticipated costs, of which $266 million has already been incurred — is expected to be substantially complete by year-end. Some of the operating leverage in the guidance comes from genuine expense reduction, not accounting mechanics. That's the one genuinely positive thread.

Valuation versus the business reality

Under Armour trades at 0.55 times trailing sales and 0.60 times EV/sales, with a $2.73 billion market cap. For comparison, Nike trades at 1.34 times sales with a $62.3 billion market cap and 13.5 times EV/EBITDA. The multiple compression on Under Armour is severe.

But revenue is declining at a mid-single-digit rate, gross margin improvement depends on expiring tariff refunds, and the company faces $35 million in Middle East supply chain headwinds. Free cash flow over the trailing twelve months was negative $162 million. Total debt stands at $3.0 billion against $309 million in cash. The debt-to-equity ratio is 84%, and return on invested capital is negative 18%. This is not a company that has figured out how to grow its way out of trouble.

The valuation is cheap, but it is cheap for reasons that are still playing out, not reasons that have been solved. A mid-single-digit revenue decline, negative free cash flow, and heavy debt for a company in the consumer athletic apparel space is not a classic "too cheap to ignore" setup. The cheapness is a feature of the business trajectory, not a temporary mispricing.

What would change the thesis

The case for a Buy rating would require evidence that North American demand has stabilized, or a demonstration that the company's cost-cutting program creates enough operating leverage to generate positive free cash flow on declining revenue. Neither has happened yet.

The restructuring program is nearly complete by the company's own timeline. If it can convert the expense reductions into sustained positive free cash flow while keeping gross margin above 50% without the refund tailwind, the story changes. If North America stops declining — even at a low-single-digit contraction rate instead of the current 9% quarterly pace — it would signal the brand repositioning is taking hold.

The next earnings report in late October (Q2 fiscal 2027) will show whether the second half of the calendar year, which typically includes back-to-school and holiday demand, provides any inflection point. UBS correctly assessed that Q1 was unlikely to be a major catalyst, but the guidance cut was still a meaningful negative. Future quarters need to show stabilization, not just a steady state of decline.

Rating: Hold

Under Armour is not a buy at this point. The valuation is compressed, but the business is still deteriorating in its core market, the profitability story depends on expiring government refunds, and free cash flow remains negative. The stock has room to fall if demand continues to slide or Middle East supply chain costs prove more persistent than the $35 million management has modeled. It also has room to recover if the cost-cutting generates real cash flow and North America stabilizes, but that recovery path requires proof that does not yet exist.

The right move for now is to watch the Q2 print and full-year guidance update for evidence that the revenue decline is narrowing and that operating income can be sustained without the tariff refund tailwind. Until then, the risk/reward does not support a Buy.